Non-Invasive Prenatal Testing - Global Market Outlook (2018-2027)
According to Stratistics MRC, the Global Non-Invasive Prenatal Testing market is accounted for $3.43 billion in 2018 and is expected to reach $11.62 billion by 2027 growing at a CAGR of 14.5% during the forecast period. Some of the key factors such as increasing programs related to awareness and growing maternal period are driving the market growth. However, lack of capable professionals is the restraining factor for the growth of the market.
Non-invasive prenatal testing is as well known as non-invasive parenteral screening, which is a hopeful genetic method of investigative a fetal cell free DNA there in the mothers blood serum for detecting general fetal aneuploidies. Its most important purpose is early recognition of genetic disorders such as trisomy 18 (Edward syndrome), trisomy 21 (Down syndrome), and monosomy X (Turner syndrome). It can as well distinguish the blood group and rhesus actor of the fetus.
By method, down syndrome (Trisomy 21) segment is likely to have a huge demand as it includes positive birth defects, education problems, and facial description. A child with Down syndrome can also contain heart defects and trouble with vision and hearing. According to the centres for illness control and prevention, it is the mostly general chromosomal situation diagnosed in United States. Every year, about six thousands babies born in the United States have Down syndrome. This way that Down syndrome occurs in about one out of each seven hundred babies. On the basis of geography, North America is going to have a lucrative growth during the forecast period due to favourable compensation policies and rise in the occurrence of genetic disorders. This will enlarge the acceptance and command for tests in this region.
Some of the key players in Non-Invasive Prenatal Testing Market include Illumina, Inc , Thermo Fisher Scientific, Inc, GE Healthcare, Perkinelmer Inc, Agilent Technologies, Inc, Beijing Genomics Institute, F. Hoffman-La Roche Ltd., and Laboratory Corporation of America Holdings, Natera, Inc, Yourgene Health, Quest Diagnostics, Sequenom, Bioarray S.L, Berry Genomics and LifeCodexx AG.
Methods Covered:
• Microdeletion Syndrome
• Trisomy
• Turner Syndrome
• Cell-Free DNA in Maternal Plasma Tests
• Biochemical Screening Tests
• Sex Chromosomes Disorders
• Ultrasound Screening
• Fetal Cells in Maternal Blood Tests
• Other Methods
Products Covered:
• Consumables
• Instruments
• Services
• Software
Gestation Periods Covered:
• 25-36 weeks
• 0-12 weeks
• 13-24 weeks
Risk-Types Covered:
• Low Risk
• High & Average Risk
Test Types Covered:
• Verifi Test
• MaterniT21 PLUS Test
• NIFTY Test
• Harmony Test
• PrenaTest
• Panorama Test
• Sequenom Test
• IONA Test
• Bambni Test
End Users Covered:
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Non-Invasive Prenatal Testing Market, By Method
5.1 Introduction
5.2 Microdeletion Syndrome
5.3 Trisomy
5.3.1 Patau Syndrome (Trisomy 13)
5.3.2 Down Syndrome (Trisomy 21)
5.3.3 Edwards Syndrome (Trisomy 18)
5.4 Turner Syndrome
5.5 Cell-Free DNA in Maternal Plasma Tests
5.6 Biochemical Screening Tests
5.7 Sex Chromosomes Disorders
5.8 Ultrasound Screening
5.9 Fetal Cells in Maternal Blood Tests
5.10 Other Methods
5.10.1 Cystic Fibrosis
5.10.2 Sex Determination
6 Global Non-Invasive Prenatal Testing Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Assay Kits & Reagents
6.2.2 Disposables
6.3 Instruments
6.3.1 Polymerase Chain Reaction Instruments
6.3.2 Nuchal Translucency Ultrasound Devices
6.3.3 Whole Genome Sequencing (WGS)
6.3.4 Next-Generation Sequencing Systems
6.3.5 Microarrays
6.3.6 Other Instruments
6.3.6.1 Microscopes
6.3.6.2 Centrifuges
6.3.6.3 Incubators
6.3.6.4 UV Systems
6.4 Services
6.5 Software
7 Global Non-Invasive Prenatal Testing Market, By Gestation Period
7.1 Introduction
7.2 25-36 weeks
7.3 0-12 weeks
7.4 13-24 weeks
8 Global Non-Invasive Prenatal Testing Market, By Risk-Type
8.1 Introduction
8.2 Low Risk
8.3 High & Average Risk
9 Global Non-Invasive Prenatal Testing Market, By Test Type
9.1 Introduction
9.2 Verifi Test
9.3 MaterniT21 PLUS Test
9.4 NIFTY Test
9.5 Harmony Test
9.6 PrenaTest
9.7 Panorama Test
9.8 Sequenom Test
9.9 IONA Test
9.10 Bambni Test
10 Global Non-Invasive Prenatal Testing Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Academic and Research Institutes
11 Global Non-Invasive Prenatal Testing Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Illumina Inc
13.2 Thermo Fisher Scientific Inc
13.3 GE Healthcare
13.4 Perkinelmer Inc
13.5 Agilent Technologies Inc
13.6 Beijing Genomics Institute
13.7 F. Hoffman-La Roche Ltd
13.8 Laboratory Corporation of America Holdings
13.9 Natera Inc
13.10 Yourgene Health
13.11 Quest Diagnostics
13.12 Sequenom
13.13 Bioarray S.L
13.14 Berry Genomics
13.15 LifeCodexx AG
List of Tables
1 Global Non-Invasive Prenatal Testing Market Outlook, By Region (2017-2027) ($MN)
2 Global Non-Invasive Prenatal Testing Market Outlook, By Method (2017-2027) ($MN)
3 Global Non-Invasive Prenatal Testing Market Outlook, By Microdeletion Syndrome (2017-2027) ($MN)
4 Global Non-Invasive Prenatal Testing Market Outlook, By Trisomy (2017-2027) ($MN)
5 Global Non-Invasive Prenatal Testing Market Outlook, By Patau Syndrome (Trisomy 13) (2017-2027) ($MN)
6 Global Non-Invasive Prenatal Testing Market Outlook, By Down Syndrome (Trisomy 21) (2017-2027) ($MN)
7 Global Non-Invasive Prenatal Testing Market Outlook, By Edwards Syndrome (Trisomy 18) (2017-2027) ($MN)
8 Global Non-Invasive Prenatal Testing Market Outlook, By Turner Syndrome (2017-2027) ($MN)
9 Global Non-Invasive Prenatal Testing Market Outlook, By Cell-Free DNA in Maternal Plasma Tests (2017-2027) ($MN)
10 Global Non-Invasive Prenatal Testing Market Outlook, By Biochemical Screening Tests (2017-2027) ($MN)
11 Global Non-Invasive Prenatal Testing Market Outlook, By Sex Chromosomes Disorders (2017-2027) ($MN)
12 Global Non-Invasive Prenatal Testing Market Outlook, By Ultrasound Screening (2017-2027) ($MN)
13 Global Non-Invasive Prenatal Testing Market Outlook, By Fetal Cells in Maternal Blood Tests (2017-2027) ($MN)
14 Global Non-Invasive Prenatal Testing Market Outlook, By Other Methods (2017-2027) ($MN)
15 Global Non-Invasive Prenatal Testing Market Outlook, By Cystic Fibrosis (2017-2027) ($MN)
16 Global Non-Invasive Prenatal Testing Market Outlook, By Sex Determination (2017-2027) ($MN)
17 Global Non-Invasive Prenatal Testing Market Outlook, By Product (2017-2027) ($MN)
18 Global Non-Invasive Prenatal Testing Market Outlook, By Consumables (2017-2027) ($MN)
19 Global Non-Invasive Prenatal Testing Market Outlook, By Assay Kits & Reagents (2017-2027) ($MN)
20 Global Non-Invasive Prenatal Testing Market Outlook, By Disposables (2017-2027) ($MN)
21 Global Non-Invasive Prenatal Testing Market Outlook, By Instruments (2017-2027) ($MN)
22 Global Non-Invasive Prenatal Testing Market Outlook, By Polymerase Chain Reaction Instruments (2017-2027) ($MN)
23 Global Non-Invasive Prenatal Testing Market Outlook, By Nuchal Translucency Ultrasound Devices (2017-2027) ($MN)
24 Global Non-Invasive Prenatal Testing Market Outlook, By Whole Genome Sequencing (WGS) (2017-2027) ($MN)
25 Global Non-Invasive Prenatal Testing Market Outlook, By Next-Generation Sequencing Systems (2017-2027) ($MN)
26 Global Non-Invasive Prenatal Testing Market Outlook, By Microarrays (2017-2027) ($MN)
27 Global Non-Invasive Prenatal Testing Market Outlook, By Other Instruments (2017-2027) ($MN)
28 Global Non-Invasive Prenatal Testing Market Outlook, By Services (2017-2027) ($MN)
29 Global Non-Invasive Prenatal Testing Market Outlook, By Software (2017-2027) ($MN)
30 Global Non-Invasive Prenatal Testing Market Outlook, By Gestation Period (2017-2027) ($MN)
31 Global Non-Invasive Prenatal Testing Market Outlook, By 25-36 weeks (2017-2027) ($MN)
32 Global Non-Invasive Prenatal Testing Market Outlook, By 0-12 weeks (2017-2027) ($MN)
33 Global Non-Invasive Prenatal Testing Market Outlook, By 13-24 weeks (2017-2027) ($MN)
34 Global Non-Invasive Prenatal Testing Market Outlook, By Risk-Type (2017-2027) ($MN)
35 Global Non-Invasive Prenatal Testing Market Outlook, By Low Risk (2017-2027) ($MN)
36 Global Non-Invasive Prenatal Testing Market Outlook, By High & Average Risk (2017-2027) ($MN)
37 Global Non-Invasive Prenatal Testing Market Outlook, By Test Type (2017-2027) ($MN)
38 Global Non-Invasive Prenatal Testing Market Outlook, By Verifi Test (2017-2027) ($MN)
39 Global Non-Invasive Prenatal Testing Market Outlook, By MaterniT21 PLUS Test (2017-2027) ($MN)
40 Global Non-Invasive Prenatal Testing Market Outlook, By NIFTY Test (2017-2027) ($MN)
41 Global Non-Invasive Prenatal Testing Market Outlook, By Harmony Test (2017-2027) ($MN)
42 Global Non-Invasive Prenatal Testing Market Outlook, By PrenaTest (2017-2027) ($MN)
43 Global Non-Invasive Prenatal Testing Market Outlook, By Panorama Test (2017-2027) ($MN)
44 Global Non-Invasive Prenatal Testing Market Outlook, By Sequenom Test (2017-2027) ($MN)
45 Global Non-Invasive Prenatal Testing Market Outlook, By IONA Test (2017-2027) ($MN)
46 Global Non-Invasive Prenatal Testing Market Outlook, By Bambni Test (2017-2027) ($MN)
47 Global Non-Invasive Prenatal Testing Market Outlook, By End User (2017-2027) ($MN)
48 Global Non-Invasive Prenatal Testing Market Outlook, By Hospitals (2017-2027) ($MN)
49 Global Non-Invasive Prenatal Testing Market Outlook, By Diagnostic Laboratories (2017-2027) ($MN)
50 Global Non-Invasive Prenatal Testing Market Outlook, By Academic and Research Institutes (2017-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above,
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.